Haemodialysis acutely reduces the plasma levels of ADMA without reversing impaired NO-dependent vasodilation

Clinical Science

Volumn 117, Issue 8, 2009, Pages 293-303

  Engelberger, Rolf P ^a   Teta, Daniel ^a   Henry, Hughes ^a   de Senarclens, Olivier ^a   Dischl, Benoît ^a   Liaudets, Lucas ^a   Burnier, Michel ^a   Waeber, Bernard ^a   Feihl, François ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Asymmetric NG,NG dimethylarginine (ADMA); Chronic haemodialysis; Endothelium dependent vasodilation; Endstage renal disease; Nitric oxide; Skin blood flow

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; RECOMBINANT ERYTHROPOIETIN;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; FOREARM; HEATING; HEMODIALYSIS; HUMAN; HYPEREMIA; HYPERTENSION; KIDNEY FAILURE; LASER DOPPLER FLOWMETRY; MALE; MICROCIRCULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN BLOOD FLOW; TANDEM MASS SPECTROMETRY; VASODILATATION;

AGED; AGED, 80 AND OVER; ARGININE; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NITRIC OXIDE; REGIONAL BLOOD FLOW; RENAL DIALYSIS; SKIN; SKIN TEMPERATURE; VASODILATION;

EID: 70349437005     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080561     Document Type: Article

References (68)

1. Foley, R. N., Parfrey, P. S. and Sarnak, M. J. (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 32, S112-S119
2. Zoccali, C. (2006) Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int. 70, 26-33
3. Vallance, P. and Leiper, J. (2004) Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway. Arterioscler. Thromb. Vasc. Biol. 24, 1023-1030
4. Tatematsu, S., Wakino, S., Kanda, T., Homma, K., Yoshioka, K., Hasegawa, K., Sugano, N., Kimoto, M., Saruta, T. and Hayashi, K. (2007) Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease. J. Am. Soc. Nephrol. 18, 741-749
5. Fliser, D., Kronenberg, F., Kielstein, J. T., Morath, C., Bode-Boger, S. M., Haller, H. and Ritz, E. (2005) Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study. J. Am. Soc. Nephrol. 16, 2456-2461
6. Ravani, P., Tripepi, G., Malberti, F., Testa, S., Mallamaci, F. and Zoccali, C. (2005) Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J. Am. Soc. Nephrol. 16, 2449-2455
7. Zoccali, C., Bode-Boger, S., Mallamaci, F., Benedetto, F., Tripepi, G., Malatino, L., Cataliotti, A., Bellanuova, I., Fermo, I., Frolich, J. and Boger, R. (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358, 2113-2117
8. Matsumoto, Y., Ueda, S., Yamagishi, S., Matsuguma, K., Shibata, R., Fukami, K., Matsuoka, H., Imaizumi, T. and Okuda, S. (2007) Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease. J. Am. Soc. Nephrol. 18, 1525-1533
9. Leiper, J., Nandi, M., Torondel, B., Murray-Rust, J., Malaki, M., O'Hara, B., Rossiter, S., Anthony, S., Madhani, M., Selwood, D. et al. (2007) Disruption of methylarginine metabolism impairs vascular homeostasis. Nat. Med. 13, 198-203
10. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362, 801-809
11. Kari, J. A., Donald, A. E., Vallance, D. T., Bruckdorfer, K. R., Leone, A., Mullen, M. J., Bunce, T., Dorado, B., Deanfield, J. E. and Rees, L. (1997) Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int. 52, 468-472
12. Thambyrajah, J., Landray, M. J., McGlynn, F. J., Jones, H. J., Wheeler, D. C. and Townend, J. N. (2000) Abnormalities of endothelial function in patients with predialysis renal failure. Heart 83, 205-209
13. Lerman, A. and Burnett, Jr, J. C. (1992) Intact and altered endothelium in regulation of vasomotion. Circulation 86, III12-III19
14. Passauer, J., Pistrosch, F., Bussemaker, E., Lassig, G., Herbrig, K. and Gross, P. (2005) Reduced agonist-induced endothelium-dependent vasodilation in uremia is attributable to an impairment of vascular nitric oxide. J. Am. Soc. Nephrol. 16, 959-965
15. Boger, R. H., Bode-Boger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F. and Cooke, J. P. (1998) Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 98, 1842-1847
16. Jacobi, J. and Tsao, P. S. (2008) Asymmetrical dimethylarginine in renal disease: limits of variation or variation limits? A systematic review. Am. J. Nephrol. 28, 224-237
17. Engelberger, R., Teta, D., Henri, H., Dischl, B., De Senarclens, O., Liaudet, L., Feihl, F., B. Waeber, B. and M. Burnier, M. (2008) Haemodialysis acutely reduces plasma asymetric dimethylarginine without reversing impaired nitric oxide dependent vasodilation. Nephrol. Dialysis Transplant. Plus 1 (Suppl. 2), ii418
18. Cracowski, J. L., Minson, C. T., Salvat-Melis, M. and Halliwill, J. R. (2006) Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol. Sci. 27, 503-508
19. Minson, C. T., Berry, L. T. and Joyner, M. J. (2001) Nitric oxide and neurally mediated regulation of skin blood flow during local heating. J. Appl. Physiol. 91, 1619-1626
20. Kellogg, Jr, D. L., Zhao, J. L. and Wu, Y. (2008) Neuronal nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo. J. Physiol. 586, 847-857
21. Medow, M. S., Minson, C. T. and Stewart, J. M. (2005) Decreased microvascular nitric oxide-dependent vasodilation in postural tachycardia syndrome. Circulation 112, 2611-2618
22. Kruger, A., Stewart, J., Sahityani, R., O'Riordan, E., Thompson, C., Adler, S., Garrick, R., Vallance, P. and Goligorsky, M. S. (2006) Laser Doppler flowmetry detection of endothelial dysfunction in end-stage renal disease patients: correlation with cardiovascular risk. Kidney Int. 70, 157-164
23. Kubli, S., Waeber, B., Dalle-Ave, A. and Feihl, F. (2000) Reproducibility of laser-Doppler imaging of skin blood flow as a tool to assess endothelial function. J. Cardiovasc. Pharmacol. 36, 640-648
24. Golay, S., Haeberli, C., Delachaux, A., Liaudet, L., Kucera, P., Waeber, B. and Feihl, F. (2004) Local heating of human skin causes hyperemia without mediation by muscarinic cholinergic receptors or prostanoids. J. Appl. Physiol. 97, 1781-1786
25. Ciplak, M., Pasche, A., Heim, A., Haeberli, C., Waeber, B., Liaudet, L., Feihl, F. and Engelberger, R. (2009) The vasodilatory response of skin microcirculation to local heating is subject to desensitization. Microcirculation 16, 265-275
26. Taylor, W. F., Johnson, J. M., O'Leary, D. and Park, M. K. (1984) Effect of high local temperature on reflex cutaneous vasodilation. J. Appl. Physiol. 57, 191-196
27. Hand, M. F., Haynes, W. G. and Webb, D. J. (1998) Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. Kidney Int. 53, 1068-1077
28. Kielstein, J. T., Boger, R. H., Bode-Boger, S. M., Schaffer, J., Barbey, M., Koch, K. M. and Frolich, J. C. (1999) Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J. Am. Soc. Nephrol. 10, 594-600
29. Hewitson, C. L., Whiting, M. J., Barbara, J. A. and Mangoni, A. A. (2007) Acute effects of haemodialysis on biochemical modulators of endothelial function. J. Intern. Med. 262, 571-580
30. Fleck, C., Janz, A., Schweitzer, F., Karge, E., Schwertfeger, M. and Stein, G. (2001) Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in renal failure patients. Kidney Int. Suppl. 78, S14-S18
31. Fleck, C., Schweitzer, F., Karge, E., Busch, M. and Stein, G. (2003) Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases. Clin. Chim. Acta 336, 1-12
32. da Silva, C. D., Brunini, T. M., Reis, P. F., Moss, M. B., Santos, S. F., Roberts, N. B., Ellory, J. C., Mann, G. E. and Mendes-Ribeiro, A. C. (2005) Effects of nutritional status on the L-arginine-nitric oxide pathway in platelets from hemodialysis patients. Kidney Int. 68, 2173-2179
33. Mochizuki, S., Ono, J., Yada, T., Ogasawara, Y., Miyasaka, T., Kimoto, M., Kashihara, N. and Kajiya, F. (2005) Systemic nitric oxide production rate during hemodialysis and its relationship with nitric oxide-related factors. Blood Purif. 23, 317-324
34. Reis, P. F., da Silva, C. D., Brunini, T. M., Moss, M. B., Siqueira, M. A., Santos, S. F., Roberts, N. B., Ellory, J. C., Mann, G. E. and Mendes-Ribeiro, A. C. (2006) Plasma amino acid profile and L-arginine uptake in red blood cells from malnourished uremic patients. J. Renal Nutr. 16, 325-331
35. Baylis, C. (2008) Nitric oxide deficiency in chronic kidney disease. Am. J. Physiol. Renal Physiol. 294, F1-F9
36. Wahbi, N., Dalton, R. N., Turner, C., Denton, M., Abbs, I. and Swaminathan, R. (2001) Dimethylarginines in chronic renal failure. J. Clin. Pathol. 54, 470-473
37. Schiel, R., Franke, S., Busch, M., Muller, A., Fleck, C., Muller, U. A., Braun, A. and Stein, G. (2003) Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency. Eur. J. Med. Res. 8, 283-291
38. Martens-Lobenhoffer, J., Krug, O. and Bode-Boger, S. M. (2004) Determination of arginine and asymmetric dimethylarginine (ADMA) in human plasma by liquid chromatography/mass spectrometry with the isotope dilution technique. J. Mass Spectrom. 39, 1287-1294
39. G-monomethyl-L-arginine in human end-stage renal failure patients on regular haemodialysis. Exp. Physiol. 81, 475-481
40. Kang, E. S., Tevlin, M. T., Wang, Y. B., Chiang, T. M., Cardenas, R., Myers, L. K. and Acchiardo, S. R. (1999) Hemodialysis hypotension: interaction of inhibitors, iNOS, and the interdialytic period. Am. J. Med. Sci. 317, 9-21
41. Bergamini, S., Vandelli, L., Bellei, E., Rota, C., Manfredini, P., Tomasi, A., Albertazzi, A. and Iannone, A. (2004) Relationship of asymmetric dimethylarginine to haemodialysis hypotension. Nitric Oxide 11, 273-278
42. Kalousova, M., Kielstein, J. T., Hodkova, M., Zima, T., Dusilova-Sulkova, S., Martens-Lobenhoffer, J. and Bode-Boger, S. M. (2006) No benefit of hemodiafiltration over hemodialysis in lowering elevated levels of asymmetric dimethylarginine in ESRD patients. Blood Purif. 24, 439-444
43. Bode-Boger, S. M., Scalera, F. and Ignarro, L. J. (2007) The L-arginine paradox: importance of the L-arginine/asymmetrical dimethylarginine ratio. Pharmacol. Ther. 114, 295-306
44. Kielstein, J. T., Boger, R. H., Bode-Boger, S. M., Martens-Lobenhoffer, J., Lonnemann, G., Frolich, J. C., Haller, H. and Fliser, D. (2004) Low dialysance of asymmetric dimethylarginine (ADMA): in vivo and in vitro evidence of significant protein binding. Clin. Nephrol. 62, 295-300
45. Billecke, S. S., Kitzmiller, L. A., Northrup, J. J., Whitesall, S. E., Kimoto, M., Hinz, A. V. and D'Alecy, L. G. (2006) Contribution of whole blood to the control of plasma asymmetrical dimethylarginine. Am. J. Physiol. Heart Circ. Physiol. 291, H1788-H1796
46. Cardounel, A. J., Cui, H., Samouilov, A., Johnson, W., Kearns, P., Tsai, A. L., Berka, V. and Zweier, J. L. (2007) Evidence for the pathophysiological role of endogenous methylarginines in regulation of endothelial NO production and vascular function. J. Biol. Chem. 282, 879-887
47. Stewart, J., Kohen, A., Brouder, D., Rahim, F., Adler, S., Garrick, R. and Goligorsky, M. S. (2004) Noninvasive interrogation of microvasculature for signs of endothelial dysfunction in patients with chronic renal failure. Am. J. Physiol. Heart Circ. Physiol. 287, H2687-H2696
48. Noon, J. P., Walker, B. R., Webb, D. J., Shore, A. C., Holton, D. W., Edwards, H. V. and Watt, G. C. (1997) Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J. Clin. Invest. 99, 1873-1879
49. Feihl, F., Liaudet, L., Waeber, B. and Levy, B. I. (2006) Hypertension, a disease of the microcirculation? Hypertension 48, 1012-1017
50. Cooke, J. P. (2003) NO and angiogenesis. Atheroscler. Suppl. 4, 53-60
51. O'Riordan, E., Mendelev, N., Patschan, S., Patschan, D., Eskander, J., Cohen-Gould, L., Chander, P. and Goligorsky, M. S. (2007) Chronic NOS inhibition actuates endothelial-mesenchymal transformation. Am. J. Physiol. Heart Circ. Physiol. 292, H285-H294
52. Kosch, M., Levers, A., Barenbrock, M., Matzkies, F., Schaefer, R. M., Kisters, K., Rahn, K. H. and Hausberg, M. (2001) Acute effects of haemodialysis on endothelial function and large artery elasticity. Nephrol. Dial. Transplant. 16, 1663-1668
53. Cupisti, A., Rossi, M., Placidi, S., Caprioli, R., Morelli, E., Vagheggini, G. and Barsotti, G. (2000) Responses of the skin microcirculation to acetylcholine and to sodium nitroprusside in chronic uremic patients. Int. J. Clin. Lab. Res, 30, 157-162
54. Miyazaki, H., Matsuoka, H., Itabe, H., Usui, M., Ueda, S., Okuda, S. and Imaizumi, T. (2000) Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer. Circulation 101, 1002-1006
55. Lilien, M. R., Koomans, H. A. and Schroder, C. H. (2005) Hemodialysis acutely impairs endothelial function in children. Pediatr. Nephrol. 20, 200-204
56. Kosch, M., Levers, A., Fobker, M., Barenbrock, M., Schaefer, R. M., Rahn, K. H. and Hausberg, M. (2003) Dialysis filter type determines the acute effect of haemodialysis on endothelial function and oxidative stress. Nephrol. Dial. Transplant. 18, 1370-1375
57. Cross, J. M., Donald, A., Vallance, P. J., Deanfield, J. E., Woolfson, R. G. and MacAllister, R. J. (2001) Dialysis improves endothelial function in humans. Nephrol. Dial. Transplant. 16, 1823-1829
58. McGregor, D. O., Buttimore, A. L., Lynn, K. L., Yandle, T. and Nicholls, M. G. (2003) Effects of long and short hemodialysis on endothelial function: a short-term study. Kidney Int. 63, 709-715
59. Chan, C. T., Harvey, P. J., Boger, R., Pierratos, A. and Floras, J. S. (2005) Dissociation between the short-term effects of nocturnal hemodialysis on endothelium dependent vasodilation and plasma ADMA. Arterioscler. Thromb. Vasc. Biol. 25, 2685-2686
60. Mittermayer, F., Schaller, G., Pleiner, J., Vychytil, A., Sunder-Plassmann, G., Horl, W. H. and Wolzt, M. (2005) Asymmetrical dimethylarginine plasma concentrations are related to basal nitric oxide release but not endothelium-dependent vasodilation of resistance arteries in peritoneal dialysis patients. J. Am. Soc. Nephrol. 16, 1832-1838
61. Yilmaz, M. I., Saglam, M., Caglar, K., Cakir, E., Ozgurtas, T., Sonmez, A., Eyileten, T., Yenicesu, M., Acikel, C., Oguz, Y. et al. (2005) Endothelial functions improve with decrease in asymmetric dimethylarginine (ADMA) levels after renal transplantation. Transplantation 80, 1660-1666
62. Cross, J. M., Donald, A. E., Kharbanda, R., Deanfield, J. E., Woolfson, R. G. and MacAllister, R. J. (2001) Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure. Kidney Int. 60, 2318-2323
63. Kielstein, J. T. and Zoccali, C. (2005) Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am. J. Kidney Dis. 46, 186-202
64. Linden, E., Cai, W., He, J. C., Xue, C., Li, Z., Winston, J., Vlassara, H. and Uribarri, J. (2008) Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation. Clin. J. Am. Soc. Nephrol. 3, 691-698
65. van der Sande, F. M., Rosales, L. M., Brener, Z., Kooman, J. P., Kuhlmann, M., Handelman, G., Greenwood, R. N., Carter, M., Schneditz, D., Leunissen, K. M. and Levin, N. W. (2005) Effect of ultrafiltration on thermal variables, skin temperature, skin blood flow, and energy expenditure during ultrapure hemodialysis. J. Am. Soc. Nephrol. 16, 1824-1831
66. Kellogg, Jr, D. L. (2006) In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges. J. Appl. Physiol. 100, 1709-1718
67. Vij, R. S., Motiwala, S. and Peixoto, A. J. (2008) Reproducibility of systemic hemodynamics in stable chronic hemodialysis: a pilot study. Blood Pressure Monit. 13, 291-294
68. Daugirdas, J. T. (1993) Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J. Am. Soc. Nephrol. 4, 1205-1213